Sign inJoin waitlistJoin the waitlist

Joshi Alumkal

Director, MCTP Epigenetic Therapies · University of Michigan

Credentials: · · · ·

History

Medical Oncology
2001–2003
Internal Medicine
1998–2001
Baylor College of Medicine
1994–1998

Research

Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study
The Lancet · 2010 · 875 citations
Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study
Journal of Clinical Oncology · 2018 · 673 citations
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
Cell · 2018 · 551 citations

TB
Tomasz Beer
45 papers
Eric Small
36 papers
Rahul Aggarwal
34 papers
Felix Feng
31 papers
GT
George Thomas
29 papers
Christopher Evans
18 papers
Matthew Rettig
18 papers
Peter Nelson
17 papers
Jiaoti Huang
16 papers · 1 as a resident
JG
Julie Graff
16 papers
CR
Charles Ryan
15 papers
Robert Reiter
15 papers

Grants

Michigan Prostate SPORE 2025-2030
National Cancer Institute · P50
Project lead · $916.7K · University of Michigan at Ann Arbor
2014–2030
Targeting Early Drivers of Prostate Cancer Lineage Plasticity
National Cancer Institute · R01
Contact PI · $1M · University of Michigan at Ann Arbor
2025–2030
Developing New Treatment Strategies for Neuroendocrine Prostate Cancer
National Cancer Institute · R01
Contact PI · $1.6M · University of Michigan at Ann Arbor
2024–2029
Targeting Prostate Cancer Lineage Plasticity with BET Bromodomain Inhibition
National Cancer Institute · R01
Contact PI · $1.9M · University of Michigan at Ann Arbor
2020–2025

Clinical trials

Molecular Features and Pathways in Predicting Drug Resistance in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide
Principal investigator · Completed
OHSU Knight Cancer Institute
2013–2020
Sulforaphane in Treating Patients With Recurrent Prostate Cancer
Principal investigator · Completed · Phase 2
OHSU Knight Cancer Institute
2010–2013